Manufacturer
Omeros
- Products listed
- 2
- Molecules
- 2
- Therapy areas
- 2
Omeros is a pharmaceutical manufacturer based in an unrecorded country. MedsAcross lists 2 of its products across 2 molecules, each with registers, packs and availability for export supply to licensed buyers.
- Indian manufacturer
- No
- Also listed as
- Omeros Corporation
- US FDA labeler
- YesSource: openFDA NDC directory
Source from this manufacturer
We supply Omeros products through licensed channels, with the documents your regulator needs.
Ophthalmology
1 presentation
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Omidria 2.88 mg/10.16 mg per mL injectionIntraocular | Ketorolac and Phenylephrine | US FDA | Available on request |
Oncology
1 presentation
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Yartemlea 370 mg/2 mL injectionIntravenous Cold chain | Narsoplimab | US FDA | Available on request |
Molecules made
Manufacturer facts come from public registers and are shown with their source. Listing does not mean the manufacturer endorses MedsAcross.
Source from Omeros
Send a request for any of these products. We confirm the licensed source, documents and lead time.